Most Alzheimer's patients would pay up to $26500 a year for a new Leqembi treatment

Retrieved on: 2023-01-10 00:32:58

Tags for this article:

Health

Articles

Healthcare reform in the United States

Alzheimer's disease

Federal assistance in the United States

Medicare

Presidency of Lyndon B. Johnson

Food and Drug Administration

Pharmaceutical industry

Mild cognitive impairment

Tricia Neuman

Eisai

Click the tags to see associated articles and topics

Most Alzheimer's patients would pay up to $26500 a year for a new Leqembi treatment. View article details on HISWAI: https://www.thebharatexpressnews.com/most-alzheimers-patients-would-pay-up-to-26500-a-year-for-a-new-leqembi-treatment/

Excerpt

The Food and Drug Administration granted accelerated approval Friday to Biogen and Eisai's monoclonal antibody after the treatment appeared to ...

Article found on: www.thebharatexpressnews.com

View Original Article